Drug factory · FDA FEI 3002807824

Siegfried Evionnaz SA

36 Route du Simplon 1, Evionnaz, Switzerland

Switzerland: 1

Problems found, fixed voluntarily at FDA's last inspection, Mar 31, 2023.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

6 drug inspections on record since 2008: 3 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
PhenelzineMakes the active ingredient Parke-Davis Div of Pfizer Inc 0071-0350
TetracaineMakes the active ingredient Alcon Laboratories, Inc. 0065-0741
ZanubrutinibMakes the active ingredient and tests it BeOne Medicines USA, Inc. 72579-122

FDA inspection history

EndedResultProgramProblems noted
Mar 31, 2023Problems found, fixed voluntarilyDrug Quality Assurance—
Jun 7, 2019No problems foundDrug Quality Assurance—
Mar 18, 2016No problems foundDrug Quality Assurance—
Nov 14, 2013No problems foundDrug Quality Assurance—
Sep 2, 2011Problems found, fixed voluntarilyDrug Quality Assurance—
Nov 14, 2008Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis; api manufacture.